The Impact of COVID-19 is included in Adenovirus Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Adenovirus Vaccine Trends and Forecast
The future of the global adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets. The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Adenovirus Vaccine by Segment
The study includes a forecast for the global adenovirus vaccine by type, application, and region.
Adenovirus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Type 4 Vaccine
• Type 7 Vaccine
Adenovirus Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Research and Academic
• Laboratories
• Pharmaceutical & Biotechnology
Adenovirus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Adenovirus Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adenovirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adenovirus vaccine companies profiled in this report include-
• Novasep
• Charles River Laboratories
• Uniqure
• Waisman Biomanufacturing
• Creative-Biogene
• Aldevron
• Addgene
• Thermo Fisher Scientific
• Fujifilm Corporation
• Spark Therapeutics
Adenovirus Vaccine Market Insights
Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.
North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.
Features of the Global Adenovirus Vaccine Market
Market Size Estimates: Adenovirus vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Adenovirus vaccine market size by type, application, and region in terms of value ($B).
Regional Analysis: Adenovirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adenovirus vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adenovirus vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the adenovirus vaccine market size?
Answer: The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030.
Q.2 What is the growth forecast for adenovirus vaccine market?
Answer: The global adenovirus vaccine market is expected to grow with a CAGR of 7.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the adenovirus vaccine market?
Answer: The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.
Q4. What are the major segments for adenovirus vaccine market?
Answer: The future of the adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets.
Q5. Who are the key adenovirus vaccine market companies?
Answer: Some of the key adenovirus vaccine companies are as follows:
• Novasep
• Charles River Laboratories
• Uniqure
• Waisman Biomanufacturing
• Creative-Biogene
• Aldevron
• Addgene
• Thermo Fisher Scientific
• Fujifilm Corporation
• Spark Therapeutics
Q6. Which adenovirus vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.
Q7. In adenovirus vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the adenovirus vaccine market by type (type 4 vaccine and type 7 vaccine), application (research and academic, laboratories, and pharmaceutical & biotechnology), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Adenovirus Vaccine Market, Adenovirus Vaccine Market Size, Adenovirus Vaccine Market Growth, Adenovirus Vaccine Market Analysis, Adenovirus Vaccine Market Report, Adenovirus Vaccine Market Share, Adenovirus Vaccine Market Trends, Adenovirus Vaccine Market Forecast, Adenovirus Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Adenovirus Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Adenovirus Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Adenovirus Vaccine Market by Type
3.3.1: Type 4 Vaccine
3.3.2: Type 7 Vaccine
3.4: Global Adenovirus Vaccine Market by Application
3.4.1: Research and Academic
3.4.2: Laboratories
3.4.3: Pharmaceutical & Biotechnology
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Adenovirus Vaccine Market by Region
4.2: North American Adenovirus Vaccine Market
4.2.2: North American Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
4.3: European Adenovirus Vaccine Market
4.3.1: European Adenovirus Vaccine Market by Type: Type 4 Vaccine and Type 7 Vaccine
4.3.2: European Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
4.4: APAC Adenovirus Vaccine Market
4.4.1: APAC Adenovirus Vaccine Market by Type: Type 4 Vaccine and Type 7 Vaccine
4.4.2: APAC Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
4.5: ROW Adenovirus Vaccine Market
4.5.1: ROW Adenovirus Vaccine Market by Type: Type 4 Vaccine and Type 7 Vaccine
4.5.2: ROW Adenovirus Vaccine Market by Application: Research and Academic, Laboratories, and Pharmaceutical & Biotechnology
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Adenovirus Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Adenovirus Vaccine Market by Application
6.1.3: Growth Opportunities for the Global Adenovirus Vaccine Market by Region
6.2: Emerging Trends in the Global Adenovirus Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Adenovirus Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adenovirus Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Novasep
7.2: Charles River Laboratories
7.3: uniQure
7.4: Waisman Biomanufacturing
7.5: Creative-Biogene
7.6: Aldevron
7.7: Addgene
7.8: Thermo Fisher Scientific
7.9: Fujifilm Corporation
7.10: Spark Therapeutics
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Adenovirus Vaccine Market Report.